ANIK Anika Therapeutics Inc. - Common Stock
$21.67
价格 · 八月 19, 2026
截至...的财报数据 七月 29, 2026
ANIK 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$21.67
市值
$301M
P/E (TTM)
-28.5
每股收益 (TTM)
$-0.76
营收 (TTM)
$113M
股息收益率
—
ROE
-7.5%
负债/权益
—
52周区间
$8 – $23
ANIK 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$113M
2016-12-31
→
2025-12-31
EPS
$-0.76
2016-12-31
→
2025-12-31
自由现金流
$4M
2016-12-31
→
2025-12-31
利润率
-9.6%
2020-12-31
→
2025-12-31
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
ANIK
同行中位数
P/E (TTM)
-28.5
—
P/S (TTM) (市销率 (TTM))
2.7
50.2
P/B (市净率)
2.1
1.0
Price / FCF (股价/自由现金流)
69.0
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
ANIK
同行中位数
Gross Margin (毛利率)
56.6%
65.5%
Operating Margin (营业利润率)
-9.8%
—
Net Profit Margin (净利润率)
-9.6%
-800.4%
ROA
-5.5%
-40.4%
ROE
-7.5%
-43.7%
ROIC
-8.3%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
ANIK
同行中位数
Current Ratio (流动比率)
4.7
7.3
Quick Ratio (速动比率)
4.8
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
ANIK
同行中位数
Revenue YoY (营收同比增长)
-5.9%
—
Revenue CAGR 3Y (营收3年复合年增长率)
-0.30%
—
Revenue CAGR 5Y (营收5年复合年增长率)
-2.9%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
ANIK
同行中位数
ANIK 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
8 位分析师
- 强烈买入 3 37.5%
- 买入 4 50.0%
- 持有 1 12.5%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
2 位分析师 · 2026-08-18
最低
$21.00
最高
$21.00
中位数目标
$21.00
-3.1%
平均目标
$21.00
-3.1%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.18%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $0.42 | $-0.08 | 0.50% |
| 2026年3月31日 | $0.27 | $-0.16 | 0.43% |
| 2025年12月31日 | $0.02 | $-0.22 | 0.24% |
| 2025年9月30日 | $-0.16 | $-0.28 | 0.12% |
| 2025年6月30日 | $-0.28 | $-0.26 | -0.02% |
| 2025年3月31日 | $-0.34 | $-0.15 | -0.19% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
| AVXL | $771M | -16.5 | -36.1% | -991.4% | -47.7% | — |
| VNDA | $521M | -2.4 | 8.7% | -102.0% | -54.2% | — |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | — |
| CAMP | $318M | -2.3 | 436.5% | -2298.5% | -183.4% | — |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| ELDN | $114M | -2.9 | — | — | -69.4% | — |
| ALXO | $61M | -0.6 | — | — | -225.0% | — |
| SRZN | — | — | — | — | — | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $113M | $120M | $121M | $114M | $148M | $130M | $115M | $106M | $113M | $103M | $93M | $106M | |
| Cost of Revenue | $49M | $44M | $38M | $41M | $65M | $61M | $29M | $31M | $27M | $24M | $21M | $21M | |
| Gross Profit | $64M | $76M | $83M | $73M | $83M | $69M | $86M | $74M | · | · | · | · | |
| R&D Expense | $26M | $26M | $22M | $18M | $27M | $23M | $17M | $18M | $19M | $11M | $9M | $8M | |
| SG&A Expense | $49M | $56M | $60M | $51M | $74M | $60M | $35M | $34M | $22M | $18M | $15M | $15M | |
| Operating Expenses | $75M | $81M | $82M | $70M | $80M | $97M | $52M | $53M | $68M | $53M | $45M | $44M | |
| Operating Income | $-11M | $-5M | $844.0K | $4M | $3M | $-28M | $34M | $22M | $46M | $51M | $48M | $61M | |
| Pretax Income | $-9M | $-3M | $3M | $4M | $2M | $-29M | $36M | $23M | $46M | $51M | $48M | $62M | |
| Income Tax | $672.0K | $6M | $7M | $2M | $-2M | $-5M | $9M | $4M | $14M | $18M | $17M | $23M | |
| Net Income | $-11M | $-56M | $-83M | $-15M | $4M | $-24M | $27M | $19M | $32M | $33M | $31M | $38M | |
| EPS (Basic) | $-0.76 | $-3.83 | $-5.64 | $-1.02 | $0.29 | $-1.69 | $1.93 | $1.30 | $2.18 | $2.22 | $2.06 | $2.61 | |
| EPS (Diluted) | $-0.76 | $-3.83 | $-5.64 | $-1.02 | $0.28 | $-1.69 | $1.89 | $1.27 | $2.11 | $2.15 | $2.01 | $2.51 | |
| Shares (Basic) | 14,339,000 | 14,721,000 | 14,656,000 | 14,561,000 | 14,401,000 | 14,222,000 | 14,121,000 | 14,442,000 | 14,575,000 | 14,682,000 | 14,934,000 | 14,678,000 | |
| Shares (Diluted) | 14,339,000 | 14,721,000 | 14,656,000 | 14,787,000 | 14,634,000 | 14,222,000 | 14,374,000 | 14,689,000 | 15,068,000 | 15,116,000 | 15,321,000 | 15,269,000 | |
| EBITDA | $-11M | $-5M | · | $-19M | $3M | $-28M | $34M | $22M | $46M | $51M | $48M | $61M |
资产负债表 25
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $57M | $56M | $69M | $86M | $94M | $96M | $157M | $89M | $133M | $104M | $111M | $100M | |
| Short-term Investments | $24M | $24M | $26M | $35M | $30M | $3M | $27M | $70M | $24M | $20M | $28M | $7M | |
| Receivables | $24M | $24M | $26M | $35M | $30M | $24M | $23M | $21M | $24M | $28M | $22M | $17M | |
| Inventory | $19M | $24M | $24M | $40M | $36M | $46M | $22M | $21M | $22M | $16M | $15M | $12M | |
| Prepaid Expense | $3M | $5M | $7M | $9M | $8M | $9M | $4M | $2M | $3M | $2M | $1M | $1M | |
| Current Assets | $103M | $114M | $163M | $170M | $169M | $177M | $234M | $203M | $206M | $170M | $176M | $138M | |
| PP&E (Net) | $40M | $39M | $37M | $48M | $48M | $51M | $51M | $54M | $56M | $52M | $40M | $32M | |
| PP&E (Gross) | $92M | $85M | $81M | $94M | $87M | $85M | $79M | $78M | $76M | $79M | $65M | $54M | |
| Accum. Depreciation | $51M | $46M | $44M | $46M | $40M | $35M | $29M | $24M | $20M | $27M | $25M | $22M | |
| Goodwill | $8M | $7M | $8M | $7M | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | |
| Intangibles | $2M | $2M | $3M | $75M | $82M | $91M | $8M | $9M | $11M | $10M | $12M | $15M | |
| Other Non-current Assets | $4M | $6M | $6M | $17M | $20M | $15M | $7M | $5M | $1M | $69.0K | · | · | |
| Total Assets | $190M | $203M | $271M | $349M | $348M | $366M | $331M | $279M | $283M | $240M | $236M | $193M | |
| Accounts Payable | $6M | $6M | $6M | $9M | $8M | $9M | $4M | $3M | $7M | $2M | $8M | $1M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | $6M | $6M | $6M | $5M | |
| Current Liabilities | $22M | $23M | $31M | $28M | $30M | $37M | $16M | $11M | $13M | $9M | $17M | $6M | |
| Capital Leases | $24M | $24M | $26M | $29M | $19M | $21M | $21M | · | · | · | · | · | |
| Deferred Tax | · | · | $0 | $6M | $10M | $12M | $4M | $4M | $5M | $7M | $7M | $8M | |
| Other Non-current Liabilities | $701.0K | $772.0K | $404.0K | $398.0K | $1M | $1M | $357.0K | $550.0K | $660.0K | $2M | $781.0K | $894.0K | |
| Common Stock | $139.0K | $144.0K | $147.0K | $146.0K | $144.0K | $143.0K | $143.0K | $142.0K | $147.0K | $146.0K | $150.0K | $149.0K | |
| Retained Earnings | $61M | $72M | $128M | $211M | $226M | $221M | $245M | $218M | $200M | $168M | $136M | $105M | |
| AOCI | $-5M | $-7M | $-6M | $-6M | $-6M | $-5M | $-6M | $-6M | $-5M | $-7M | $-7M | $-4M | |
| Stockholders' Equity | $143M | $154M | $212M | $286M | $287M | $272M | $288M | $264M | $263M | $223M | $211M | $178M | |
| Liabilities + Equity | $190M | $203M | $271M | $349M | $348M | $366M | $331M | $279M | $283M | $240M | $236M | $193M | |
| Shares Outstanding | 13,889,000 | 14,416,000 | 14,660,000 | 14,625,000 | 14,441,000 | 14,329,000 | 14,308,000 | 14,210,000 | 14,688,000 | 14,627,000 | 15,037,000 | 14,851,703 |
现金流 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $7M | $6M | $7M | $6M | $6M | $5M | $6M | $4M | $4M | $4M | $5M | |
| Stock-based Comp | $10M | $13M | $15M | $14M | $11M | $5M | $6M | $11M | $6M | $3M | $2M | $2M | |
| Deferred Tax | $-7.0K | $260.0K | $-6M | $-5M | $-2M | $-4M | $794.0K | $-2M | $-1M | $-65.0K | $-747.0K | $815.0K | |
| Amort. of Intangibles | $400.0K | $700.0K | $600.0K | $600.0K | $8M | $7M | $1M | $1M | $1M | $1M | $1M | $2M | |
| Operating Cash Flow | $11M | $5M | $-2M | $4M | $8M | $13M | $37M | $35M | $41M | $24M | $40M | $40M | |
| CapEx | $7M | $8M | $5M | $7M | $5M | $2M | $3M | $5M | $9M | $14M | $9M | $2M | |
| Investing Cash Flow | $-401.0K | $-8M | $-5M | $-7M | $-3M | $-71M | $40M | $-50M | $-12M | $-7M | $-30M | $-8M | |
| Debt Issued | · | · | · | $0 | $0 | $50M | $0 | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | $0 | $0 | $-350.0K | · | · | · | · | · | · | |
| Stock Repurchased | $9M | $11M | $5M | $0 | $0 | $0 | $30M | $30M | · | $25M | · | · | |
| Net Stock Activity | $-9M | $-11M | · | · | $0 | $0 | $-30M | $-30M | · | $-25M | · | · | |
| Financing Cash Flow | $-11M | $-13M | $-6M | $-5M | $-7M | $-4M | $-8M | $-29M | $314.0K | $-24M | $1M | $5M | |
| Net Change in Cash | $322.0K | $-16M | $-13M | $-8M | $-1M | $-62M | $68M | $-44M | $29M | $-6M | $11M | $37M | |
| Taxes Paid | $1M | $4M | $3M | $106.0K | $1M | $993.0K | $9M | · | · | · | · | · | |
| Free Cash Flow | $4M | $-2M | · | $-3M | $3M | $11M | $34M | $30M | $32M | $10M | $30M | $38M |
盈利能力 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 56.6% | 63.4% | · | 59.9% | 56.1% | 52.9% | · | · | · | · | · | · | |
| Operating Margin | -9.8% | -4.2% | · | -12.4% | 1.8% | -21.7% | 29.9% | 20.6% | 40.3% | 48.9% | 51.8% | 58.2% | |
| Net Margin | -9.6% | -47.0% | · | -9.5% | 2.8% | -18.4% | 23.7% | 17.7% | 28.1% | 31.5% | 33.1% | 36.3% | |
| Pretax Margin | -8.2% | -2.3% | · | -12.0% | 1.6% | -21.9% | 31.5% | 22.0% | 40.7% | 49.2% | 51.9% | 58.2% | |
| EBITDA Margin | -9.8% | -4.2% | · | -12.4% | 1.8% | -21.7% | 29.9% | 20.6% | 40.3% | 48.9% | 51.8% | 58.2% | |
| ROA | -5.5% | -23.8% | · | -4.3% | 1.2% | -6.9% | 8.9% | 6.7% | 12.2% | 13.7% | 14.3% | 21.9% | |
| ROE | -7.5% | -33.8% | · | -5.2% | 1.4% | -8.6% | 9.5% | 7.2% | 13.1% | 15.0% | 15.8% | 24.4% | |
| ROIC | -8.3% | -10.6% | · | -5.4% | 1.6% | -8.7% | 8.9% | 6.7% | 11.9% | 14.5% | 14.5% | 21.5% |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 4.9 | · | 6.1 | 5.7 | 4.8 | 14.4 | 18.0 | 15.8 | 19.4 | 10.2 | 23.3 | |
| Quick Ratio | 4.8 | 4.4 | · | 5.6 | 4.2 | 3.3 | 12.8 | 15.9 | 13.9 | 17.3 | 9.3 | 20.8 |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | · | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | |
| Inventory Turnover | 2.3 | 1.8 | · | 1.7 | 1.6 | 1.4 | 1.3 | 1.4 | 1.4 | 1.6 | 1.5 | 1.8 | |
| Receivables Turnover | 4.8 | 4.8 | · | 4.4 | 5.5 | 5.5 | 5.2 | 4.7 | 4.4 | 4.2 | 4.8 | 5.9 |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -5.9% | -0.73% | 6.1% | -23.0% | 13.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -0.30% | -6.7% | -2.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -2.9% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $113M | $120M | $121M | $114M | $148M | $130M | $115M | $106M | $113M | $103M | $93M | $106M | |
| Net Income TTM | $-11M | $-56M | $-83M | $-15M | $4M | $-24M | $27M | $19M | $32M | $33M | $31M | $38M | |
| Market Cap | $133M | $237M | · | $433M | $517M | $649M | $742M | $478M | $792M | $716M | $574M | $605M | |
| P/E | -12.6 | -4.3 | -4.0 | -29.0 | 128.0 | -26.8 | 27.4 | 26.5 | 25.5 | 22.8 | 19.0 | 16.2 | |
| P/S | 1.2 | 2.0 | · | 3.8 | 3.5 | 5.0 | 6.5 | 4.5 | 7.0 | 6.9 | 6.2 | 5.7 | |
| P/B | 0.9 | 1.5 | · | 1.5 | 1.8 | 2.4 | 2.6 | 1.8 | 3.0 | 3.2 | 2.7 | 3.4 | |
| P / Tangible Book | 1.0 | 1.6 | 1.6 | 2.1 | 2.6 | 3.8 | · | · | · | · | · | · | |
| P / Cash Flow | 11.9 | 43.9 | · | 98.2 | 61.6 | 49.6 | 20.0 | 13.7 | 19.4 | 30.1 | 14.7 | 15.1 | |
| P / FCF | 30.6 | -101.8 | · | -140.7 | 159.0 | 56.7 | 21.7 | 15.8 | 24.9 | 73.2 | 19.2 | 15.7 | |
| Earnings Yield | -7.9% | -23.3% | -24.9% | -3.5% | 0.78% | -3.7% | 3.6% | 3.8% | 3.9% | 4.4% | 5.3% | 6.2% |
损益表 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33M | $30M | $31M | $28M | $28M | $26M | $31M | $30M | $31M | $29M | $-3M | $41M | $44M | $38M | $-3M | $40M | |
| Cost of Revenue | $11M | $11M | $11M | $12M | $14M | $11M | $13M | $10M | $10M | $10M | $-9M | $17M | $15M | $15M | $-7M | $17M | |
| Gross Profit | $21M | $19M | $19M | $16M | $14M | $15M | $17M | $19M | $20M | $19M | $6M | $25M | $29M | $23M | $4M | $23M | |
| R&D Expense | $7M | $7M | $6M | $7M | $6M | $6M | $7M | $6M | $7M | $6M | $-3M | $8M | $9M | $8M | $-2M | $7M | |
| SG&A Expense | $11M | $18M | $12M | $12M | $12M | $13M | $11M | $14M | $16M | $15M | $-16M | $25M | $24M | $27M | $-11M | $21M | |
| Operating Expenses | $18M | $24M | $19M | $19M | $19M | $19M | $18M | $19M | $22M | $21M | $-19M | $33M | $33M | $35M | $-13M | $29M | |
| Operating Income | $3M | $-5M | $646.0K | $-3M | $-4M | $-4M | $-705.0K | $-81.0K | $-2M | $-3M | $25M | $-8M | $-4M | $-13M | $16M | $-6M | |
| Pretax Income | $3M | $-5M | $764.0K | $-2M | $-4M | $-4M | $39.0K | $325.0K | $-1M | $-2M | $25M | $-7M | $-3M | $-12M | $17M | $-5M | |
| Income Tax | $71.0K | $235.0K | $-1M | $939.0K | $681.0K | $89.0K | $3M | $2M | $1M | $43.0K | $9M | $-463.0K | $-329.0K | $-2M | $5M | $-1M | |
| Net Income | $3M | $-5M | $292.0K | $-2M | $-4M | $-5M | $-22M | $-30M | $-88.0K | $-5M | $-63M | $-7M | $-3M | $-10M | $-5M | $-4M | |
| EPS (Basic) | $0.25 | $-0.37 | $0.02 | $-0.16 | $-0.28 | $-0.34 | $-1.48 | $-2.03 | $-0.01 | $-0.31 | $-4.29 | $-0.45 | $-0.19 | $-0.71 | $-0.33 | $-0.29 | |
| EPS (Diluted) | $0.24 | $-0.37 | $0.02 | $-0.16 | $-0.28 | $-0.34 | $-1.49 | $-2.03 | $0.00 | $-0.31 | $-4.29 | $-0.45 | $-0.19 | $-0.71 | $-0.33 | $-0.29 | |
| Shares (Basic) | 13,330,000 | 13,531,000 | -28,741,000 | 14,419,000 | 14,364,000 | 14,297,000 | -29,584,000 | 14,768,000 | 14,839,000 | 14,698,000 | -29,320,000 | 14,635,000 | 14,688,000 | 14,653,000 | -29,063,000 | 14,603,000 | |
| Shares (Diluted) | 13,717,000 | 13,531,000 | -28,894,000 | 14,419,000 | 14,517,000 | 14,297,000 | -29,601,000 | 14,768,000 | 14,856,000 | 14,698,000 | -29,320,000 | 14,635,000 | 14,688,000 | 14,653,000 | -28,837,000 | 14,603,000 | |
| EBITDA | $3M | $-5M | · | $-3M | $-4M | $-4M | · | $-28M | $161.0K | $-5M | · | $-8M | $-4M | $-13M | · | $-6M |
资产负债表 24
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $38M | $41M | $57M | $58M | $53M | $53M | $56M | $62M | $63M | $69M | · | $71M | $65M | $80M | · | $88M | |
| Short-term Investments | · | $26M | $24M | $22M | $24M | $22M | $24M | $28M | $34M | $32M | · | $35M | $37M | $31M | · | $34M | |
| Receivables | $29M | $26M | $24M | $22M | $24M | $22M | $24M | $28M | $34M | $32M | · | $35M | $37M | $31M | · | · | |
| Inventory | $29M | $23M | $19M | $16M | $17M | $21M | $24M | $40M | $51M | $49M | · | $44M | $43M | $41M | · | $37M | |
| Prepaid Expense | $3M | $4M | $3M | $5M | $5M | $6M | $5M | $6M | $7M | $9M | · | $8M | $8M | $9M | · | $9M | |
| Current Assets | $99M | $94M | $103M | $102M | $99M | $103M | $114M | $136M | $155M | $159M | · | $157M | $152M | $160M | · | $168M | |
| PP&E (Net) | $40M | $40M | $40M | $41M | $41M | $40M | $39M | $45M | $48M | $46M | · | $46M | $48M | $49M | · | $47M | |
| PP&E (Gross) | $94M | $92M | $92M | · | $90M | $88M | $85M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $54M | $53M | $51M | · | $49M | $48M | $46M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | $7M | $7M | $8M | $7M | $7M | $7M | $7M | $7M | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $4M | $4M | · | $69M | $71M | $73M | · | $77M | |
| Other Non-current Assets | $3M | $4M | $4M | $6M | $6M | $6M | $6M | $11M | $20M | $18M | · | $19M | $19M | $18M | · | $18M | |
| Total Assets | $183M | $179M | $190M | $189M | $188M | $191M | $203M | $231M | $263M | $264M | · | $328M | $329M | $339M | · | $348M | |
| Accounts Payable | $6M | $6M | $6M | $5M | $5M | $5M | $6M | $7M | $10M | $10M | · | $8M | $8M | $9M | · | $8M | |
| Current Liabilities | $22M | $21M | $22M | $19M | $16M | $18M | $23M | $25M | $26M | $28M | · | $28M | $23M | $29M | · | $26M | |
| Capital Leases | $23M | $24M | $24M | $23M | $23M | $24M | $24M | $25M | $26M | $26M | · | $27M | $28M | $28M | · | $29M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $2M | $3M | $4M | · | $7M | |
| Other Non-current Liabilities | $730.0K | $726.0K | $701.0K | $761.0K | $756.0K | $744.0K | $772.0K | $806.0K | $407.0K | $404.0K | · | $400.0K | $401.0K | $399.0K | · | $474.0K | |
| Common Stock | $134.0K | $133.0K | $139.0K | $144.0K | $144.0K | $143.0K | $144.0K | $147.0K | $148.0K | $148.0K | · | $146.0K | $147.0K | $147.0K | · | $146.0K | |
| Retained Earnings | $59M | $56M | $61M | $60M | $63M | $67M | $72M | $94M | $123M | $124M | · | $191M | $198M | $200M | · | $216M | |
| AOCI | $-5M | $-5M | $-5M | $-5M | $-5M | $-6M | $-7M | $-6M | $-6M | $-6M | · | $-7M | $-6M | $-6M | · | $-7M | |
| Stockholders' Equity | $137M | $134M | $143M | $147M | $148M | $148M | $154M | $180M | $210M | $209M | $212M | $270M | $274M | $278M | $286M | $285M | |
| Liabilities + Equity | $183M | $179M | $190M | $189M | $188M | $191M | $203M | $231M | $263M | $264M | · | $328M | $329M | $339M | · | $348M | |
| Shares Outstanding | 13,383,000 | 13,357,000 | 13,889,000 | 14,421,000 | 14,418,000 | 14,336,000 | 14,416,000 | 14,694,000 | 14,839,000 | 14,821,000 | · | 14,637,000 | 14,657,000 | 14,741,000 | · | 14,607,000 |
现金流 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $2M | $7M | $2M | $2M | $3M | $3M | $2M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Deferred Tax | $129.0K | $108.0K | $-25.0K | $3.0K | $-3.0K | $18.0K | $234.0K | $-184.0K | $17.0K | $193.0K | $-2M | $-1M | $-904.0K | $-2M | $-2M | $-1M | |
| Amort. of Intangibles | · | · | $0 | $0 | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $100.0K | $-5M | $2M | $2M | $2M | $-5M | $2M | |
| Restructuring | $519.0K | $2M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-684.0K | $-5M | $5M | $7M | $-189.0K | $-130.0K | $2M | $5M | $-1M | $-126.0K | $4M | $6M | $-8M | $-4M | $481.0K | $3M | |
| CapEx | $1M | $1M | $648.0K | $2M | $1M | $3M | $1M | $1M | $3M | $2M | $2M | $741.0K | $1M | $1M | $3M | $2M | |
| Investing Cash Flow | $-1M | $-1M | $198.0K | $-2M | $-539.0K | $2M | $-1M | $-2M | $-3M | $-2M | $-2M | $-741.0K | $-1M | $-1M | $-3M | $-2M | |
| Stock Repurchased | $853.0K | $9M | $6M | $0 | $0 | $4M | $6M | $4M | $1M | $0 | $0 | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | $-9M | · | · | · | $-4M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-701.0K | $-10M | $-5M | $-13.0K | $179.0K | $-5M | $-5M | $-4M | $-1M | $-2M | $342.0K | $-110.0K | $-5M | $-2M | $667.0K | $-5M | |
| Net Change in Cash | $-3M | $-16M | $-509.0K | $5M | $-204.0K | $-4M | $-5M | $-454.0K | $-6M | $-4M | $2M | $6M | $-15M | $-7M | $-1M | $-4M | |
| Free Cash Flow | · | $-6M | · | · | · | $-3M | · | · | · | $-2M | · | · | · | $-5M | · | · |
盈利能力 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.1% | 64.1% | · | 56.0% | 50.9% | 56.1% | · | 3.7% | 65.3% | 60.8% | · | 60.2% | 65.4% | 60.2% | · | 56.6% | |
| Operating Margin | 9.1% | -18.5% | · | -11.6% | -14.8% | -16.4% | · | -72.3% | 0.38% | -12.5% | · | -18.5% | -8.2% | -33.1% | · | -14.4% | |
| Net Margin | 10.2% | -17.1% | · | -8.4% | -14.1% | -18.6% | · | -77.2% | -0.21% | -11.1% | · | -15.9% | -6.2% | -27.3% | · | -10.4% | |
| Pretax Margin | 10.4% | -16.3% | · | -8.0% | -14.1% | -14.8% | · | -71.2% | 1.8% | -11.0% | · | -17.0% | -6.9% | -31.7% | · | -13.3% | |
| EBITDA Margin | 9.1% | -18.5% | · | -11.6% | -14.8% | -16.4% | · | -72.3% | 0.38% | -12.5% | · | -18.5% | -8.2% | -33.1% | · | -14.4% | |
| ROA | 1.8% | -2.7% | · | -1.1% | -1.8% | -2.1% | · | -10.7% | -0.03% | -1.5% | · | -1.9% | -0.80% | -3.0% | · | -1.2% | |
| ROE | 2.3% | -3.6% | · | -1.4% | -2.2% | -2.7% | · | -13.3% | -0.04% | -1.9% | · | -2.4% | -0.98% | -3.7% | · | -1.5% | |
| ROIC | 2.1% | -4.3% | · | -3.1% | -3.3% | -2.9% | · | -16.9% | -0.01% | -2.5% | · | -2.6% | -1.2% | -3.9% | · | -1.6% |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 4.5 | · | 5.3 | 6.2 | 5.7 | · | 5.3 | 5.9 | 5.6 | · | 5.6 | 6.5 | 5.6 | · | 6.4 | |
| Quick Ratio | 3.0 | 4.4 | · | 5.4 | 6.3 | 5.4 | · | 4.7 | 5.0 | 4.7 | · | 5.0 | 5.9 | 4.9 | · | 4.6 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.3 | · | 0.9 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.1 | 1.0 | 1.0 | · | 1.2 | 1.2 | 1.3 | · | 1.2 | 1.3 | 1.3 | · | · |
估值 (TTM) 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $118M | $112M | · | $112M | $115M | $115M | · | $131M | $146M | $153M | · | $164M | $162M | $155M | · | $156M | |
| Net Income TTM | $-8M | $-16M | · | $-41M | $-39M | $-39M | · | $-41M | $-14M | $-24M | · | $-24M | $-20M | $-20M | · | $-9M | |
| Market Cap | $196M | $194M | · | $136M | $153M | $215M | · | $363M | $376M | $376M | · | $273M | $381M | $423M | · | $348M | |
| P/E | -25.7 | -12.6 | · | -3.3 | -4.0 | -5.6 | · | -8.9 | -26.7 | -15.3 | · | -11.4 | -18.7 | -20.5 | · | -36.6 | |
| P/S | 1.7 | 1.7 | · | 1.2 | 1.3 | 1.9 | · | 2.8 | 2.6 | 2.5 | · | 1.7 | 2.3 | 2.7 | · | 2.2 | |
| P/B | 1.4 | 1.4 | · | 0.9 | 1.0 | 1.5 | · | 2.0 | 1.8 | 1.8 | · | 1.0 | 1.4 | 1.5 | · | 1.2 | |
| P / Tangible Book | 1.5 | 1.6 | · | 1.0 | 1.1 | 1.6 | · | 2.1 | 1.9 | 1.9 | · | 1.4 | 1.9 | 2.1 | · | 1.7 | |
| P / Cash Flow | · | -40.0 | · | · | · | -1657.5 | · | · | · | -2987.7 | · | · | · | -117.0 | · | · | |
| P / FCF | · | -30.9 | · | · | · | -72.9 | · | · | · | -194.7 | · | · | · | -84.6 | · | · | |
| Earnings Yield | -3.9% | -7.9% | · | -29.9% | -25.1% | -17.8% | · | -11.3% | -3.8% | -6.5% | · | -8.8% | -5.3% | -4.9% | · | -2.7% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $113M | $120M | $121M | $114M | $148M |
| 毛利率 % | 56.6% | 63.4% | — | 59.9% | 56.1% |
| 营业利润率 % | -9.8% | -4.2% | — | -12.4% | 1.8% |
| 净收入 | $-11M | $-56M | $-83M | $-15M | $4M |
| 稀释后每股收益 (EPS) | $-0.76 | $-3.83 | $-5.64 | $-1.02 | $0.28 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 4.7 | 4.9 | — | 6.1 | 5.7 |
| 速动比率 | 4.8 | 4.4 | — | 5.6 | 4.2 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $4M | $-2M | — | $-3M | $3M |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 144 家申报者 · $132.7M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 24 (-1 与上一季度对比) | 12 (-4 与上一季度对比) | 42 (0 与上一季度对比) | 35 (-7 与上一季度对比) | -452K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 43 位内幕人士 · 20 位高管 · 18 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Stephen D. Griffin | President and CEO | 2026年6月3日 M | 45973 | 1 | 0 | $149938 |
| Joseph G Darling | President and CEO; Director | 2019年7月27日 F | 20289 | 0 | 0 | $0 |
| Charles H Sherwood | CEO and Director | 2018年3月2日 A | 189891 | 0 | 0 | $0 |
| Michael L Levitz | EVP, CFO, Treasurer | 2024年3月15日 A | 46955 | 0 | 0 | $0 |
| Sylvia Cheung | Chief Financial Officer | 2020年2月25日 A | 49281 | 0 | 0 | $0 |
| Kevin W Quinlan | Chief Financial Officer | 2013年3月27日 S | 27112 | 0 | 0 | $0 |
| Francesco J Luppino | Chief Operating Officer | 2015年2月3日 A | 5979 | 0 | 0 | $0 |
| Ian Mcleod | SVP, CAO & Treasurer | 2026年3月19日 A | 24107 | 0 | 0 | $0 |
| David Colleran | EVP, General Counsel, Corp Sec | 2026年3月15日 M | 67570 | 0 | 0 | $0 |
| Anne Nunes | SVP, Chief Operations Officer | 2025年3月17日 M | 20654 | 0 | 0 | $0 |
| Thomas Finnerty | EVP, Human Resources | 2022年3月9日 M | 24598 | 0 | 0 | $0 |
| James Loerop | EVP Business Development | 2021年7月8日 M | 5592 | 0 | 0 | $0 |
| Richard Hague | Chief Commercial Officer | 2019年2月27日 A | 21419 | 0 | 0 | $0 |
| Edward S. Ahn | Chief Tech & Strategy Officer | 2019年2月27日 A | 6575 | 0 | 0 | $0 |
| Dana M. Alexander | Chief Operations Officer | 2017年1月27日 A | — | 0 | 0 | $0 |
| Stephen R. Mascioli | Chief Medical Officer | 2016年4月4日 A | — | 0 | 0 | $0 |
| Carol A Barnett | Chief Commercial Officer | 2014年1月27日 A | 6100 | 0 | 0 | $0 |
| John W Sheets JR | Chief Scientific Officer | 2013年10月2日 A | 10000 | 0 | 0 | $0 |
| William Mrachek | Vice President, Human Resource | 2011年1月18日 A | 6854 | 0 | 0 | $0 |
| Constance H Garrison | VP Reg.,Clinical & Qlty. Sys. | 2006年11月8日 A | — | 0 | 0 | $0 |
| Stephen Richard | 董事 | 2026年6月18日 A | 58273 | 0 | 0 | $0 |
| Joseph H Capper | 董事 | 2026年6月18日 A | 30805 | 0 | 0 | $0 |
| Sheryl L Conley | 董事 | 2026年6月18日 A | 52970 | 0 | 0 | $0 |
| John B Henneman III | 董事 | 2026年6月18日 A | 65273 | 1 | 0 | $73300 |
| Cheryl R Blanchard | 董事 | 2026年3月15日 M | 258788 | 0 | 0 | $0 |
| Glenn R. Larsen | 董事 | 2025年6月20日 A | 50258 | 0 | 0 | $0 |
| Susan L N Vogt | 董事 | 2025年6月20日 A | 50213 | 0 | 0 | $0 |
| William R Jellison | 董事 | 2025年6月20日 A | 20403 | 0 | 0 | $0 |
| Jeffery S Thompson | 董事 | 2023年6月14日 A | 31575 | 0 | 0 | $0 |
| Raymond J Land | 董事 | 2021年6月16日 A | 12125 | 0 | 0 | $0 |
| Joseph I Bower | 董事 | 2020年2月25日 A | 17117 | 0 | 0 | $0 |
| Steve E Wheeler | 董事 | 2018年1月24日 A | 34594 | 0 | 0 | $0 |
| John C Moran | 董事 | 2015年8月7日 S | 14803 | 0 | 0 | $0 |
| Eugene A Davidson | 董事 | 2011年1月18日 A | 71763 | 0 | 0 | $0 |
| Harvey S Sadow | 董事 | 2006年9月8日 M | 10000 | 0 | 0 | $0 |
| Fidia Farmaceutici S.p.A. | 10% 所有者 | 2013年8月6日 S | 711192 | 0 | 0 | $0 |
| Gary P Fischetti | — | 2026年8月4日 P | 54015 | 2 | 0 | $41060 |
| Carol A Toth | — | 2006年1月26日 A | — | 0 | 0 | $0 |
| Samuel F Mckay | — | 2006年1月24日 A | 0 | 0 | 0 | $0 |
| Peter Litman | — | 2005年10月3日 A | — | 0 | 0 | $0 |
| James E Oneill | — | 2005年2月10日 A | — | 0 | 0 | $0 |
| Elizabeth Chen | — | 2004年10月4日 A | — | 0 | 0 | $0 |
| William J Knight | — | 2004年9月27日 M | 47500 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 3 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Caligan Partners LP, David Johnson ×6 申报 | 2026年1月27日 | 9.95% | 修订 | — | SEC |
| ANDREW E. GOLD, RONIT GOLD | 2004年11月15日 | — | 初始申报 | 被动投资 | SEC |
| 未披露的报告人 | 2004年4月22日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 35 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| GSSC · Goldman Sachs ETF Trust | 0.02% | 13535 NS | 2026年5月31日 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.01% | 24030 NS | 2026年5月31日 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund ... | 0.01% | 4805 NS | 2026年4月30日 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.01% | 41240 NS | 2026年4月30日 | N-PORT |
| AVUV · AMERICAN CENTURY ETF TRUST | 0.01% | 101973 NS | 2026年5月31日 | N-PORT |
| ITWO · ProShares Trust | 0.00% | 588 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.00% | 66746 NS | 2026年5月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 43882 NS | 2026年4月30日 | N-PORT |
| UWM · ProShares Trust | 0.00% | 459 NS | 2026年5月31日 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.00% | 28347 NS | 2026年4月30日 | N-PORT |
| URTY · ProShares Trust | 0.00% | 466 NS | 2026年5月31日 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0.00% | 385 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 502 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.00% | 12 NS | 2026年5月31日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 1000 NS | 2026年4月30日 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.00% | 6027 NS | 2026年4月30日 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 3415 NS | 2026年5月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 733 NS | 2026年4月30日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 8500 NS | 2026年5月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 1436 NS | 2026年4月30日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 1888 NS | 2026年4月30日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 900 NS | 2026年4月30日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| IWV · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWN · iShares Trust | — | — | 2026年8月17日 | 每日 |
| IWM · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWC · iShares Trust | — | — | 2026年8月18日 | 每日 |
| PKW · Invesco Exchange-Traded Fund Trust | — | — | 2026年8月4日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 2026年7月13日 | 每日 |
| OMFS · Invesco Exchange-Traded Self-Inde... | — | — | 2026年7月13日 | 每日 |
| QQQS · Invesco Exchange-Traded Fund Trus... | — | — | 2026年8月5日 | 每日 |